OUTSMART HF: A Randomized Controlled Trial of Routine Versus Selective Cardiac Magnetic Resonance for Patients With Nonischemic Heart Failure (IMAGE-HF 1B).


Journal

Circulation
ISSN: 1524-4539
Titre abrégé: Circulation
Pays: United States
ID NLM: 0147763

Informations de publication

Date de publication:
10 03 2020
Historique:
pubmed: 9 1 2020
medline: 12 11 2020
entrez: 9 1 2020
Statut: ppublish

Résumé

Cardiac magnetic resonance (CMR) is a recommended imaging test for patients with heart failure (HF); however, there is a lack of evidence showing incremental benefit over transthoracic echocardiography. Our primary hypothesis was that routine use of CMR will yield more specific diagnoses in nonischemic HF. Our secondary hypothesis was that routine use of CMR will improve patient outcomes. Patients with nonischemic HF were randomized to routine versus selective CMR. Patients in the routine strategy underwent echocardiography and CMR, whereas those assigned to selective use underwent echocardiography with or without CMR according to the clinical presentation. HF causes was classified from the imaging data as well as by the treating physician at 3 months (primary outcome). Clinical events were collected for 12 months. A total of 500 patients (344 male) with mean age 59±13 years were randomized. The routine and selective CMR strategies had similar rates of specific HF causes at 3 months clinical follow-up (44% versus 50%, respectively; In patients with nonischemic HF, routine CMR does not yield more specific HF causes on clinical assessment. Patients with specific HF causes from imaging had worse outcomes, whereas HF causes defined clinically did not. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01281384.

Sections du résumé

BACKGROUND
Cardiac magnetic resonance (CMR) is a recommended imaging test for patients with heart failure (HF); however, there is a lack of evidence showing incremental benefit over transthoracic echocardiography. Our primary hypothesis was that routine use of CMR will yield more specific diagnoses in nonischemic HF. Our secondary hypothesis was that routine use of CMR will improve patient outcomes.
METHODS
Patients with nonischemic HF were randomized to routine versus selective CMR. Patients in the routine strategy underwent echocardiography and CMR, whereas those assigned to selective use underwent echocardiography with or without CMR according to the clinical presentation. HF causes was classified from the imaging data as well as by the treating physician at 3 months (primary outcome). Clinical events were collected for 12 months.
RESULTS
A total of 500 patients (344 male) with mean age 59±13 years were randomized. The routine and selective CMR strategies had similar rates of specific HF causes at 3 months clinical follow-up (44% versus 50%, respectively;
CONCLUSIONS
In patients with nonischemic HF, routine CMR does not yield more specific HF causes on clinical assessment. Patients with specific HF causes from imaging had worse outcomes, whereas HF causes defined clinically did not. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01281384.

Identifiants

pubmed: 31910649
doi: 10.1161/CIRCULATIONAHA.119.043964
doi:

Banques de données

ClinicalTrials.gov
['NCT01281384', 'NCT01281384']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

818-827

Subventions

Organisme : CIHR
ID : CIF 99470
Pays : Canada

Investigateurs

Peter Brown (P)
Juha Kartikainen (J)
Marja Hedman (M)
Eric Larose (E)
Philippe Pibarot (P)
Jean-Claude Tardif (JC)
Jonathan Leipsic (J)
Marla Kiess (M)
Andrew Howarth (A)
Helena Hanninen (H)
Lloyd Duchesne (L)
Michael Freeman (M)
Howard Leong-Poi (H)
Graham Wright (G)
Heikki Ukkonen (H)

Auteurs

D Ian Paterson (DI)

Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Canada (D.I.P., J.E.).

George Wells (G)

School of Epidemiology and Public Health, Department of Medicine and Cardiovascular Research Methods Centre (G.W., L.C.), University of Ottawa, Ontario, Canada.

Fernanda Erthal (F)

University of Ottawa Heart Institute (F.E., L.M., B.J.W.C., R.K., A.D., C.D., L.G., K-L.C.), University of Ottawa, Ontario, Canada.

Lisa Mielniczuk (L)

University of Ottawa Heart Institute (F.E., L.M., B.J.W.C., R.K., A.D., C.D., L.G., K-L.C.), University of Ottawa, Ontario, Canada.

Eileen O'Meara (E)

Institut de Cardiologie de Montréal, Université de Montréal, Québec, Canada (E.O'M.).

James White (J)

Calgary Foothills Medical Centre, University of Calgary, Alberta, Canada (J.W.).

Kim A Connelly (KA)

Keenan Research Centre of the Li Ka Shing Knowledge Institute, St Michael's Hospital, University of Toronto, Ontario, Canada (K.A.C.).

Juhani Knuuti (J)

Turku PET Center, Turku University Hospital, University of Turku, Finland (J.K.).

Miroslaw Radja (M)

Queen Elizabeth II Hospital, Dalhousie University, Halifax, Nova Scotia, Canada (M.R.).

Mika Laine (M)

Helsinki University Central Hospital, University of Helsinki, Finland (M.L.).

Benjamin J W Chow (BJW)

University of Ottawa Heart Institute (F.E., L.M., B.J.W.C., R.K., A.D., C.D., L.G., K-L.C.), University of Ottawa, Ontario, Canada.

Riina Kandolin (R)

University of Ottawa Heart Institute (F.E., L.M., B.J.W.C., R.K., A.D., C.D., L.G., K-L.C.), University of Ottawa, Ontario, Canada.

Li Chen (L)

School of Epidemiology and Public Health, Department of Medicine and Cardiovascular Research Methods Centre (G.W., L.C.), University of Ottawa, Ontario, Canada.

Alexander Dick (A)

University of Ottawa Heart Institute (F.E., L.M., B.J.W.C., R.K., A.D., C.D., L.G., K-L.C.), University of Ottawa, Ontario, Canada.

Carole Dennie (C)

University of Ottawa Heart Institute (F.E., L.M., B.J.W.C., R.K., A.D., C.D., L.G., K-L.C.), University of Ottawa, Ontario, Canada.

Linda Garrard (L)

University of Ottawa Heart Institute (F.E., L.M., B.J.W.C., R.K., A.D., C.D., L.G., K-L.C.), University of Ottawa, Ontario, Canada.

Justin Ezekowitz (J)

Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Canada (D.I.P., J.E.).

Kwan-Leung Chan (KL)

University of Ottawa Heart Institute (F.E., L.M., B.J.W.C., R.K., A.D., C.D., L.G., K-L.C.), University of Ottawa, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH